Telmisartan, a medication prescribed to treat high blood pressure, may contribute to hair loss in some patients. This angiotensin II receptor blocker (ARB) works by relaxing blood vessels, but its effects on hair follicles remain debated.
Telmisartan's potential role in hair loss isn't well-documented, but some researchers suspect it may interfere with hair follicle cycles. A 2016 study published in PLOS ONE found that angiotensin II receptors exist in hair follicles, suggesting blood pressure medications like telmisartan could theoretically impact hair growth. However, direct evidence linking telmisartan to hair loss is limited.
Drug-induced hair loss typically falls into two categories:
| Type | Description | Example Medications |
|---|---|---|
| Telogen effluvium | Temporary shedding due to follicle cycle disruption | Antidepressants, NSAIDs |
| Alopecia areata | Autoimmune attack on hair follicles | Chemotherapy drugs |
Telmisartan, if it affects hair loss at all, likely causes telogen effluvium-a reversible condition where hair shifts prematurely into the resting phase.
Last year, a patient in my practice reported noticeable hair thinning three months after starting telmisartan. We switched them to losartan, and their hair regrowth stabilized within six months. While correlation doesn't prove causation, this case highlights the importance of tracking side effects.
Hair loss often results from multiple factors, including genetics, stress, and nutritional deficiencies. For example, demodex mites can exacerbate shedding in some individuals. Maintaining a balanced diet and managing stress may support hair health alongside medical treatments.